Wells Fargo maintains Teleflex at Equal-Weight, raises price target to $167 from $138
Wells Fargo reaffirmed Teleflex's Equal-Weight rating and increased its price target to $167 from $138, indicating a 9.8% upside from the last close of $152.15, according to the bank.
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Decision brief
The 30-second read
Med
01
Why it matters
The higher target may attract buyers and support the stock price.
02
Market read
Analyst upgrade could provide short-term buying interest.
03
What to watch
No new earnings data; price target reflects opinion, not fundamentals.
Relevance 7/10Novelty 6/10Timing: today
Background
Wells Fargo's rating update is part of its regular coverage of Teleflex.
Market effects
Sector
May lift other medical device peers.
Regional
Limited to US healthcare sector.
Global
Low
Counterpoint
What could challenge this read
Target could be overly optimistic if growth stalls.
Key entities
- companyTeleflex Inc.
Medical device manufacturer.
- analystWells Fargo
Equity research firm providing the rating.
